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Background: Synthetic Amorphous Silica (SAS) is commonly used in food and drugs. Recently, a consumer intake
of silica from food was estimated at 9.4 mg/kg bw/day, of which 1.8 mg/kg bw/day was estimated to be in the
nano-size range. Food products containing SAS have been shown to contain silica in the nanometer size range
(i.e. 5 – 200 nm) up to 43% of the total silica content. Concerns have been raised about the possible adverse effects
of chronic exposure to nanostructured silica.
Methods: Rats were orally exposed to 100, 1000 or 2500 mg/kg bw/day of SAS, or to 100, 500 or 1000 mg/kg bw/
day of NM-202 (a representative nanostructured silica for OECD testing) for 28 days, or to the highest dose of SAS
or NM-202 for 84 days.
Results: SAS and NM-202 were extensively characterized as pristine materials, but also in the feed matrix and
gut content of the animals, and after in vitro digestion. The latter indicated that the intestinal content of the
mid/high-dose groups had stronger gel-like properties than the low-dose groups, implying low gelation and high
bioaccessibility of silica in the human intestine at realistic consumer exposure levels. Exposure to SAS or NM-202
did not result in clearly elevated tissue silica levels after 28-days of exposure. However, after 84-days of exposure to
SAS, but not to NM-202, silica accumulated in the spleen. Biochemical and immunological markers in blood and
isolated cells did not indicate toxicity, but histopathological analysis, showed an increased incidence of liver fibrosis
after 84-days of exposure, which only reached significance in the NM-202 treated animals. This observation was
accompanied by a moderate, but significant increase in the expression of fibrosis-related genes in liver samples.
Conclusions: Although only few adverse effects were observed, additional studies are warranted to further evaluate
the biological relevance of observed fibrosis in liver and possible accumulation of silica in the spleen in the NM-202
and SAS exposed animals respectively. In these studies, dose-effect relations should be studied at lower dosages,
more representative of the current exposure of consumers, since only the highest dosages were used for the
present 84-day exposure study.
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Synthetic amorphous silica (SAS) is widely applied in
food products within the EU as a food additive (E551)
for several decades. Consumers are daily exposed to syn-
thetic amorphous silica used in cosmetics, medicinal
products, and food as an anticaking agent or carrier of
flavors [1-4]. SAS is a nanostructured material composed
of aggregates of primary particles in the lower nano-
meter size range [1,2,5-8]. Production methods of SAS
include wet (precipitation) and thermal (pyrogenic) pro-
cesses. SAS intended for application in foodstuffs is pre-
dominantly produced by a standard pyrogenic process in
which SiCl4 is burned in a hydrogen flame at tempera-
tures ranging from 1000 to 2500°C. This results in the
generation of primary silica nanoparticles of ~10 nm
that aggregate into particles with sizes in the order of
100 nm, which ultimately agglomerate into particles in
the larger nano- or micro-size range [1,2,6].
Recently, a consumer intake of silica from food was
estimated at 9.4 mg/kg bw/day, of which 1.8 mg/kg
bw/day was estimated to be in the nano-size range [4].
Food products containing SAS have been shown to con-
tain silica in the nanometer size range (i.e. with a size of
5 – 200 nm) in quantities up to 43% of the total silica
content [4]. This fraction of SAS in the nanometer size
range potentially reaches up to 100% in the small intes-
tine based on an in vitro simulated digestion [9]. In
this previous study, as well as in the present study,
the fraction of SAS in the nanometer range has been de-
termined with hydrodynamic chromatography induct-
ively coupled plasma mass spectroscopy (HDC-ICP-MS),
which is able to provide mass-based size distributions of
SAS from food and feed matrices in the nanometer
range. Sizes can be reliably determined in a size range of
5–200 nm, which is broader than the 1–100 nm size
range used in most legal definitions of nanoparticles.
Next to added synthetic silicon compounds, silicon also
occurs as a natural component in foodstuffs in the form
of sodium, calcium and magnesium silicates, or as hy-
drated silica SiO2-nH2O [10]. The latter may form small
(i.e. 1 to 5 nm) particles that can be found in natural
and drinking waters [5,11]. Reviews of toxicokinetics and
toxicodynamics data of SAS generally suggest safety for
consumers when exposed to SAS via food [1,2,12-14],
as indicated by a LOAEL (based on liver toxicity in rats)
of 1500 mg/kg bw/day [4]. However, concerns have been
raised over the limited characterization of the used SAS
and over the contribution (if any) of the nano-sized silica
fraction to the observed effects [14]. Since the original
SAS exposure studies, performed in the 1980’s, no oral
in vivo study has been reported in the public domain.
In vivo studies on oral exposure to SAS are required
since several recent animal studies, using precipitated
silica nanoparticles, show toxic effects in the liver in aparticle-, size-, and dose-related manner following intra-
venous or intraperitoneal exposure to silica nanoparti-
cles, which will be discussed in more detail in the results
and discussion section [15-21].
The goal of the present study was to investigate the bio-
distribution and the effects of a pyrogenically produced
food grade SAS in rats, following sub-chronic oral expos-
ure. In addition, pyrogenic NM-202 was included in the
study as a reference compound, being the OECD represen-
tative nanostructured silica for applications related to food.
During the first 28 days, six groups of rats (n = 5) were daily
fed a bolus of SAS or NM-202 at three different doses,
namely 100, 1000, and 2500 mg/kg bw of SAS, and 100,
500, and 1000 mg/kg bw of NM-202 (Table 1; Additional
file 1: Table S1). Biochemical assessment of blood from ani-
mals exposed for 28 days did not indicate systemic toxicity
of the materials. Consequently, it was decided to continue
the exposure to the highest dose of SAS or NM-202 for 84
days in two additional groups (n = 5). Two groups of con-
trol rats (n = 5), each corresponding to one of the exposure
periods, were fed carrier material only. Of all animals, tis-
sues and blood were collected for systemic toxicity, histo-
logical, and immunotoxicity analysis, and to assess tissue
distribution. Finally, mRNA was isolated from jejunum and
liver for transcriptome analysis.
Results and discussion
Material characterization: pristine materials
The SAS that was used in this study is a commercially
available food-grade, hydrophilic, pyrogenic synthetic
amorphous silica with a primary particle size of 7 nm, a
specific surface area of 380 m2/g, and a purity ≥99.8% (as
specified by the manufacturer, see materials section). NM-
202 is a representative nanostructured silica, selected by
the OECD, which is also a hydrophilic, pyrogenic synthetic
amorphous silica and has a primary particle size between
10 and 25 nm, a specific surface area of 200 m2/g, and a
purity ≥99.9% (as specified by the manufacturer, see mate-
rials section). All material properties are summarized in
Table 2. For exposure, SAS or NM-202 was mixed with
powdered standard feed pellets and chocolate milk. Sus-
pensions of both SAS and NM-202 in water containing
0.05% bovine serum albumine (BSA) as a stabilizing agent,
showed the presence of agglomerates, which appeared to
be larger in the feed mixture (Figure 1A-D), as assessed by
scanning electron microscopy (SEM). SEM was also
employed to generate number-based size distribution
data of pristine materials, suspended in water + 0.05%
BSA, which showed larger sizes for NM-202 (Figure 1E).
A fraction of 78% and 61%, of the pristine SAS and
NM-202 materials respectively, was below 100 nm. This
could possibly be higher regarding the size limit of de-
tection of 25 nm. The number-based size distribution
of SAS and NM-202 was not assessed in the feed










Silica in nano-size rangeb
(mg/kg bw/day)
SAS low 100 222 83 33
SAS medium 1000 942 819 328
SAS high 2500 2142 2047 819
NM-202 low 100 221 82 82
NM-202 medium 500 537 405 405
NM-202 high 1000 933 810 810
Negative control 0 133 0 <21
The actual exposure doses were calculated from the (HDC) ICP-MS silicon measurements in the feed mixture (0.95 ± 0.19 mg silica/g), standard feed pellets (1.8 ±
0.9 mg silica/g), and drinking water (0.019 ± 0.003 mg silica/g). Exposure to silica originating from consumption of standard feed pellets and drinking water was
based on an average feed intake of 27 g/day and an average water intake of 45 ml/day at an average body weight of 350 g [22] (for a more detailed calculation,
see Additional file 1: Table S1). aTotal silica (mg/kg bw/day) – (dose of silica from the standard diet + drinking water in mg/kg bw/day) = dose of added silica (i.e.
SAS or NM-202 in mg/kg bw/day). bWith a size of 5 – 200 nm.
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extremely diluted for measurement, thereby resulting in
non-representative data for this matrix.
X-ray photoelectron spectroscopy (XPS) analysis of




Specific surface area 200 m2/ga
Purity ≥99.9%b
Primary particle size 10-25 nma
SEM size distribution At least 61% of the material was <100 nm.c (Figu
XPS Si: 25.0 ± 0.3 at%b
O: 72.1 ± 0.4 at% b
C: 2.9 ± 0.6 at% b
EDX Presence of carbon on the surface (Figure 1F).
FTIR Large peak between 1000–1130 cm-1 and a pea
at ~800 cm-2 corresponding to Si-O bonds in a
pattern characteristic for amorphous fumed silic
Some C-H stretching vibrations at ~3000 cm-1, in
the presence of organic material on the surface.
Material c
(HDC)-ICP-MS 79.6 ± 20.7 mg silica/g feed, ~100% between 5–
SEM-EDX Presence of carbon on the material surface befo
after in vitro digestion.
Presence of salts (e.g. Ca and P, likely in the form
CaPO4) on the material surface after in vitro dige
(Additional file 1: Figure S1)
Material ch
(HDC)-ICP-MS 81, 81, 97% (low, medium and high group respe
of the material has a size between 5–200 nm
Dissolution ~15-20 wt% or less dissolves after in vitro digest
aAs specified by the manufacturer. bReported in ref [23]. cSize limit of detection at 2the surface of both materials. SAS contained 29.8 ± 0.5
at% Si, 68.1 ± 0.6 at% O, and 2.1 ± 0.6 at% C, whereas
NM-202 has previously been reported to contain 25.0 ±
0.3 at% Si, 72.1 ± 0.4 at% O, and 2.9 ± 0.6 at% C [23].






re 1E) At least 78% of the material was <100 nm.c (Figure 1E)
Si: 29.8 ± 0.5 at%
O: 68.1 ± 0.6 at%
C: 2.1 ± 0.6 at%
Presence of carbon on the surface (Figure 1F).
k
a.
Large peak between 1000–1130 cm-1 and a peak
at ~800 cm-2 corresponding to Si-O bonds in a
pattern characteristic for amorphous fumed silica.
dicating
haracterisation in the feed matrix
200 nm 80.5 ± 20.9 mg silica/g feed, ~40% between 5–200 nm
re and Presence of carbon on the material surface before
and after in vitro digestion.
of
stion.
Presence of salts (e.g. Ca and P, likely in the form of
CaPO4) on the material surface after in vitro digestion.
(Additional file 1: Figure S1)
aracterization in intestinal content
ctively) 55, 106, 54% (low, medium and high group respectively)
of the material has a size between 5–200 nm
ion. ~15-20 wt% or less dissolves after in vitro digestion.
5 nm.
Figure 1 Physicochemical characterization of synthetic amorphous silica (SAS) and the OECD representative nano-sized silica (NM-202).
SEM micrographs of SAS in (A) water + 0.05% BSA and (B) feed, and of NM-202 in (C) water + 0.05% BSA and (D) feed. (E) SEM size distribution
pattern of SAS and NM-202 in water + 0.05% BSA, showing larger sizes for NM-202. The size limit of detection lies at 25 nm. (F) EDX
characterization of SAS and NM-202 agglomerates in water containing 0.05% BSA, demonstrating the presence of Si, O, and C on the surface of
both materials. The peak representing nickel can be attributed to the nickel coated membrane that was used for sample preparation. (G) FTIR
spectra of SAS and NM-202 showing mild C-H stretching vibrations for NM-202 (inset). (H) HDC-ICP-MS chromatogram showing the size
distribution and concentration (area under the curve) of nano-sized silica in SAS, NM-202, and in control feed mixtures. (I) The fraction of silica in
the nano-size range (i.e. with a size of 5–200 nm; measured by HDC-ICP-MS) given as a percentage of the total silica content (measured by ICP-MS)
in the large intestinal (LI) contents, 24 hours after the last exposure (mean ± standard error of the mean; n = 5). * Significant difference versus the
control (p < 0.05).
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also reported previously [23]. The Si : O ratio of both
materials is below the theoretical value of 0.5, indicating
that the surface contamination likely consists of carbon-
oxygen compounds [23]. Semi-quantitative energy dis-
persive X-ray spectroscopy (EDX) data confirmed the
XPS data, and also demonstrated the presence of carbon
on the surface of SAS and NM-202 (both in water +
0.05% BSA and in the feed matrix; Figure 1F; Additional
file 1: Figure S1). EDX was also used to characterize
both materials in the feed matrix after in vitro digestion.
For this, we used the previously described in vitro diges-
tion procedures used to study the fate of nanoparticles
during in vitro human digestion [9,24-26]. The in vitro
digestion model is based on human physiological data
(i.e. transit times, pH, and composition of digestive
juices). The gastrointestinal tract is simulated for themouth, stomach, and small intestine. The large intestine
is not taken into account because in vivo absorption
mainly takes place in the small intestine. The data indi-
cated that, even after digestion, carbon was still present
on the surface of the materials, as well as some salts
(e.g. Ca and P, likely in the form of CaPO4; Additional
file 1: Figure S1). Fourier transform infrared spectros-
copy (FTIR) analysis of SAS and NM-202 showed a
large peak between 1000–1130 cm-1, as well as a peak
at ~800 cm-1, which can be attributed to Si-O bonds,
following a pattern that is characteristic of amorphous
fumed silica (Figure 1G). The presence of isolated silanol
groups on the surface of amorphous silica particles has
been described to promote cytotoxicity through their
ability to interact with cell membranes and to generate
reactive oxygen species [27]. The spectra were therefore
carefully evaluated for the presence of a peak at
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which was absent in both spectra. Furthermore, also a
peak between 3200 – 3500 cm-1, corresponding to
hydrogen bonded OH groups, was absent in both spec-
tra. The small peaks in the region from 2300–2400 cm-1
were caused by CO2 interference from the air, and are
therefore not of interest. Some C-H stretching vibrations
at ~3000 cm-1 were seen for NM-202, which appeared
to be the only minor difference between the two mate-
rials in the FTIR spectra. These stretching vibrations in-
dicate the presence of organic material on the surface of
NM-202, but not on the surface of SAS. Finally, C-O
stretching vibrations could not be detected in the spec-
tra, due to the presence of the Si-O peaks at the same
wavenumber, which makes it difficult to directly com-
pare the FTIR data with the XPS and EDX data with re-
spect to the presence of carbon on the surface of the
materials. The combination of these surface analyses of
SAS and NM-202 revealed no, or minor differences be-
tween these two materials in neither its powdered form
nor after in vitro digestion.
Material characterization: SAS and NM-202 in feed matrix
HDC-ICP-MS was used to quantify the fraction of silica
particles in the nano-size range (i.e. with a size 5–
200 nm) [9] in the SAS and NM-202 feed mixtures. As a
reference, total silica contents of both feed mixtures
were determined by conventional ICP-MS. Since (HDC)
ICP-MS measures only the Si content, all results were
converted to SiO2, and presented as SiO2 throughout
the text. The SAS feed mixture contained a fraction of
~40 wt% of silica in the nano-size range on a total silica
content of 80.5 ± 20.9 mg/g feed mixture. The NM-202
feed mixture contained a fraction of ~100 wt% of silica
in the nano-size range on a total silica content of 79.6 ±
20.7 mg/g feed mixture (Figure 1H). Lastly, the control
mixture contained only 0.95 ± 0.19 mg silica/g standard
feed pellet and no silica in the nano-size range. Follow-
ing administration of the feed mixtures, the animals also
received standard diet pellets and drinking water (ad
libitum), containing naturally occurring silica. (HDC)
ICP-MS measurements showed total silica contents of
0.019 ± 0.003 mg/g in drinking water, and 1.8 ± 0.9 mg/g
in diet pellets. Silica in the nano-size range of 5–200 nm
was absent. These combined data were used to calculate
the actual total silica and silica in the nano-size range
exposure doses (Table 1; Additional file 1: Table S1). An-
imals were fed standard feed pellets and drinking water
containing naturally occurring silica. As stated in the
introduction, the silica is likely present as soluble hy-
drated silica SiO2. nH2O and may contain small polysi-
licic acid particles in the size range of 1–5 nm. Due to
the presence of silica in every standard diet, this ap-
proach is considered a realistic exposure. However, itmust be noted that the background dose of this naturally
occurring silica contributed substantially to the actual
exposure dose of total but not nano-sized silica, in the
low dose and control groups.
Material characterization: SAS and NM-202 in intestinal
content
One day after the last exposure, the small and large in-
testinal contents of the 28-day exposed animals was also
analyzed by HDC-ICP-MS to get an impression of the
presence of silica in the nano-size range (i.e. with a size
of 5–200 nm) in the intestines. In the small intestine, be-
tween 50 and 100% of the total silica content was
present in the nano-size range in most exposure groups
versus 17% in the control group. However, taking the
gastric and gut transition times into account, implying
that most of the material has already passed the small
intestine, results from the large intestinal content pro-
vide a more realistic insight into the presence of silica in
the nano-size range in the gut. Therefore, only results
from the large intestinal content are reported here in de-
tail (Figure 1I; Additional file 1: Table S2). In the NM-
202 exposed rats ~80% of the total amount of silica was
present in the nano-size range, whereas in the SAS ex-
posed rats this was more variable (50, 100, and 50% for
the three exposure groups respectively). The control rats
had the lowest fraction of 25% of silica particles in the
nano-size range in the large intestinal content. The pres-
ence of silica in the nano-size range in the control rats
can be explained by the observation that the control feed
contains total silica (Table 1). It may be in the form of
silicic acid, or in the form of large agglomerates of silica,
which break up into nano-sized particles upon digestion,
as observed previously [9]. These results clearly illustrate
that the gut contains a substantial fraction of silica parti-
cles in the nano-size range, which appears to be 2 to 4
times higher in animals that received NM-202 or SAS.
Dissolution of silica has been reported before [28,29]
and is described to be influenced by many parameters,
including particle size, aggregation, pH [28,30], temp-
erature, and ionic strength [30]. Therefore, the potential
dissolution of SAS and NM-202 was assessed under the
harsh digestive conditions, using the in vitro digestion
approach. SAS and NM-202 suspensions in water +
0.05% BSA were digested and ultrafiltration was applied
to separate the amorphous silica agglomerates from the
dissolved silica. The silicon content before and after
ultrafiltration was then measured by ICP-MS. Dissol-
ution of silica results in the formation of silicic acid,
which may consist of both monomeric and polymeric
species [30,31]. During this process, new small particles
may be formed in the solution. In natural waters, includ-
ing drinking and mineral waters, these particles have
been described in the size range of 1–5 nm [5]. The pore
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between 6–12 nm [32], indicating that dissolved silica,
including particles up to ~12 nm, were separated from
the amorphous silica agglomerates and measured. For
this experiment, the silica concentrations were ~1000
times lower than those in the original feed mixtures,
which was required to prevent clogging of the ultrafiltra-
tion membrane. At these concentrations, no clogging
was observed. No statistical significant differences in
solubility between SAS and NM-202 were observed in
the intestinal content, although it appeared that a higher
percentage of NM-202 dissolved at low concentrations
≤50 μg/ml compared with SAS. However, at higher con-
centrations ≥100 μg/ml, dissolution of both materials
appeared to stabilize at approximately 15–20 wt%
(Figure 2). This indicates that the dissolved silica content
in the feed mixtures in the intestine was ~15-20 wt% or
possibly even slightly lower. Gastrointestinal silicic acid
absorption is reported to be variable, but it is around 40
to 50%, depending on the food that contains silicic acid
[33-35].
Silica uptake in tissues
The limit of detection for silica in the nano-size range
using HDC-ICP-MS was relatively high (i.e. 300 mg of
silica in the nano-size range/kg tissue), which rendered
this technique unsuitable to determine the amount of
silica in the nano-size range in tissues obtained from this
study. The limit of detection of SEM-EDX in a scanning
mode was estimated to be lower (~100 mg silica/kg tis-
sue) and can be even lower when examined at a single
cell level. However, no nano-sized silica could be de-
tected in the liver of exposed rats using SEM-EDX (data
not shown). Therefore, only the total silica content in
tissues, as determined by ICP-MS measurements, is re-
ported here. Thus, no information in what form silicaFigure 2 Dissolution behavior of SAS and NM-202 after digestion in v
the total silica content at concentrations ranging from 50 to 150 μg/ml (n
samples. LOD: 5 μg SiO2/mlwas taken up could be obtained. Intravenously or intra-
peritoneally administered silica nanoparticles synthesized
by a precipitation process have been described to distrib-
ute mainly to the liver and spleen [18,21,36-38], but dis-
tribution to the lung [21,38], and kidney [18] have also
been reported. In the present oral feeding study with
SAS or NM-202, no clear target organ could be identi-
fied after 28-days of exposure (Figure 3). Only in the
lower dosed NM-202 animals, significant increases in
total silica concentrations were seen in the liver, kidney,
and spleen. After 84-days of exposure, tissue distribution
was similar to that after 28-days of exposure (Table 3),
with the exception of the spleen of the animals that re-
ceived the highest dose of SAS. Here, the silica content
was significantly higher than that in spleens of the con-
trols and in spleens of animals that received a high SAS
dose for 28 days. Whereas clearly elevated silica levels
were observed in the spleen of SAS treated animals after
oral exposure to the highest dose for 84 days, exposure
to the highest dose of NM-202 for 84 days did not result
in accumulation of silica in any of the examined tissues.
It should be noted though, that the highest dose of total
silica in the NM-202 group was 2.5-fold lower that the
highest dose of total silica in the SAS group. Taking into
consideration that the dissolution of SAS and NM-202
could go up to 20 wt% in the intestinal content, it is pos-
sible that dissolved silica is absorbed and distributed to
the examined tissues.
In literature, intravenously injected silica nanoparticles
(a single dose of 50, 100, 200 nm particles administered
at 50 mg/kg bw [18], or of 20 and 80 nm particles ad-
ministered at 10 mg/kg bw [21]), were described to be
retained in liver and spleen for at least four weeks, sug-
gesting accumulative properties of silica nanoparticles.
However, direct extrapolation of these findings from
studies using monodisperse silica nanoparticles to ouritro. The content of dissolved silica is given as a weight percentage of
= 6). The dotted lines represent an extrapolated trendline for both
Figure 3 Silica content in organs of animals orally exposed to SAS or NM-202 for 28 days. Silica content was measured by ICP-MS and
presented in mg silica/kg tissue (mean ± standard error of the mean; n = 5). * Significant difference versus the control (p < 0.05).
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the differences in materials that were used and the dif-
ferences in study design. After 28-days of exposure, total
silica levels in tissues were variable, but increased up to
1.5 to 2 times in the tested tissues compared with the
controls. In the liver of the NM-202 treated rats in the
low and medium dose group (i.e. 100 and 500 mg NM-
202/kg bw/day) the total silica content was significantly
increased. In kidney and spleen this was observed only
in rats treated with the lowest dose of NM-202.
While not statistically significant, the total silica con-
tent in tissues appeared to be lower in the higher-dosed
animals compared with the lower-dosed animals, in par-
ticular for NM-202. This can be explained by the gelat-
ing behavior of silica, which has been described to occur
more readily at higher particle concentrations under
conditions with a relatively high pH and salt concentra-
tion, like in the small intestine [39]. In order to examine
this in more detail, the visco-elastic behavior of SAS andTable 3 Silica content in tissues in mg silica/kg tissue
(mean ± standard error of the mean, n=5) after 84 days
of exposure
SAS high NM-202 high Control
Liver 78 ± 2 <75* <75*
Kidney 79 ± 4 <75* <75*
Spleen 248 ± 81a,b <75* <75*b
Brain 100 ± 23 <75* <75*
Testis 105 ± 17 <75* 87 ± 12
aSignificant increase versus control, or bversus the results from the
corresponding group after 28-days of exposure (p<0.05). *Measurements were
below the limit of detection and were therefore set at the limit of detection of
75 mg silica/kg tissue.NM-202 was analyzed by rheological measurements at
different concentrations after digestion in vitro. Since sil-
ica measurements in the intestinal contents were per-
formed 24 hours after the last exposure, these data likely
underestimate the maximal silica concentration. There-
fore, silica concentrations in the intestines were esti-
mated based on physiological data from literature (i.e.
approximate secretion of mouth, gastric, and intestinal
fluids; http://www.interspeciesinfo.com/), indicating that
concentrations of 10, 50 and 75 mg/ml after in vitro di-
gestion corresponded to the low, medium, and highest
intestinal exposure doses of SAS. However, the actual
silica concentrations after in vitro digestion were some-
what lower (i.e. 9, 34, and 59 mg/ml for SAS and 8, 39,
and 55 mg/ml for NM-202) due to necessary pH adjust-
ments during the in vitro digestion procedure. The
higher storage moduli (G’) in comparison with the loss
moduli (G”) for SAS and NM-202 indicate that all sam-
ples have gel-like properties (Figure 4). The control feed
mixture also showed mild gel-like properties, which is
probably due to the presence of chocolate milk in the
mixture. The G’ and G” of the control sample were
slightly lower than, or equal to the lowest SAS and NM-
202 doses. Increasing silica concentrations however, led
to an increased G’ and G”, showing stronger gel-like
properties for the higher silica concentrations. Previ-
ously, a lower absorption of nanoparticles from gels
has been described [40], suggesting that the absorption
of silica might have been higher in the low and mid
dose groups as compared with the high dosed groups.
Considering the estimated human exposure to SAS
(i.e. 9.4 mg/kg bw/day) and silica in the nano-size
range (i.e.1.8 mg/kg bw/day) [4], which are both lower
than the concentrations used for the rheological
Figure 4 Visco-elastic behavior of SAS and NM-202 in the feed
mixture after in vitro digestion. Higher storage moduli (G’) of (A)
SAS and (C) NM-202 than loss moduli (G”) of (B) SAS and (D)
NM-202 (as a function of the strain) indicate increasing gel-like
properties, with increasing SiO2 concentrations.
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intestine might be expected.
Assessment of systemic and immunotoxic effects
Daily monitoring of body weights and tissue weights
after dissection (Additional file 1: Table S3-4) did not in-
dicate treatment related effects, or any effects indicative
of nutritional imbalance in the animals that had receivedrelatively high amounts of the food mixture (i.e. the high
dose groups). Since systemically administered silica
nanoparticles, synthesized by a precipitation process,
have been described to distribute to the liver and kidney
[18,21,36-38], also blood biochemical markers of hepatic
and kidney injury were examined. Markers evaluated for
hepatic injury were alkaline phosphatase (ALP), alanine
transaminase (ALT), aspartate transaminase (AST), and
total protein. The markers creatinine and urea were used
to evaluate kidney function. After 84-days of exposure,
the levels of lactate dehydrogenase (LDH), uric acid,
zinc, iron, high- and low-density lipoprotein, cholesterol,
glucose, and triglycerides were measured additionally to
evaluate general tissue damage and to further evaluate
liver damage. Neither after 28-, nor 84-days of exposure
were there any signs of systemic toxicity (Additional file
1: Figure S2 A-O). ALP levels after 28-days of exposure
were slightly increased in the low and high (but not
medium) NM-202 dose groups compared to the control
group, but remained within normal physiological ranges.
Moreover, the observed decrease in LDH concentration
in the NM-202 84-day exposure group did also not indi-
cate toxicity, since only increased LDH levels are associ-
ated with toxicity. These results are in contrast with
previous reports on effect after intravenous or intraperi-
toneal administration of silica nanoparticles synthesized
by a precipitation process, which showed a dose-
dependent increase in ALT and AST levels for monodis-
perse 70 nm silica nanoparticles (starting at 20 mg/kg
bw) and increased ALT levels for 110 nm silica nanopar-
ticles (at 50 mg/kg bw) [16,17,19]. However, the tissue
silica concentrations in these studies are expected to be
much higher than in the present study.
Immunotoxic effects due to any of the treatments were
also absent after both 28-, and 84-days of exposure.
No effects were seen on antibody levels (IgG and IgM)
in blood (Additional file 1: Figure S2 P, Q), or on cyto-
kine levels produced by proliferating T- and B-cells, that
were isolated from spleen and MLN in the 28-, and 84-
days exposure groups (Additional file 1: Table S5-8).
Proliferation of the isolated T- and B-cells, and the activ-
ity of NK-cells isolated from spleen was also examined
after 28-days of exposure, but remained unaffected
(Additional file 1: Figure S2 R-V).
Histological and transcriptome analysis
Histopathological evaluations were performed on je-
junum, liver, kidney and spleen. In addition, whole gen-
ome differential mRNA expression was analyzed in
jejunum epithelial tissue and liver tissue of all animals.
Histopathological assessment of the kidneys and spleen
showed no differences between the treated animals and
the controls (data not shown). In jejunum, a quantitative
measurement of the villus height and crypt depth
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heights and crypt depths, but no significant differences
in the ratio between the villus height and crypt depth for
both SAS and NM-202 treated animals after 28-days
of exposure, as compared with the controls (Additional
file 1: Figure S3). Most absorption takes place in the je-
junum, and generally speaking, long villi and a high vil-
lus:crypt ratio indicate a highly differentiated and active
tissue. Gene set enrichment analysis on microarray data
of jejunal epithelial samples from either the 28-, or 84-
days of exposure to both SAS and NM-202 did not show
differences in gene expression profiles between the treat-
ment groups and the controls (data not shown).
A quantitative histological assessment of livers indi-
cated that the number of lymphocytic cells (Figure 5A
and B) and thereby also the number of inflammatory
granulomatous foci (the average number of cells in each
of the foci was constant at ~19 cells/focus) remainedFigure 5 Histological images of livers from animals treated with SAS
inflammatory granuloma after 84-days of exposure for (A) SAS high dose (m
(C) Apoptosis after 28-days of exposure (SAS low dose, H&E staining; magn
high dose; immunohistochemically stained apoptosis; magnification: 200x).
magnification: 25x), and (F, G) fibrosis after 84-days of exposure to the (F)
(magnification 100x).unchanged after 28, and 84-days of exposure (Figure 6A).
Furthermore, also the number of apoptotic cells (Figure 5C
and D) in the livers was not significantly affected by the
28-, or 84-day treatment (Figure 6B). Necrosis (Figure 5E)
was only occasionally seen and there were no differences
between groups (data not shown). Contradictory, previous
reports described inflammation [15,17-21], lymphocytic
infiltration [17,20], increased apoptosis [17,20], necrosis
[16,19-21], and silicotic nodular-like lesions [17] in the
liver as a result of intravenous or intraperitoneal adminis-
tration of monodisperse silica nanoparticles produced by a
precipitation process of 15 nm (50 mg/kg bw) [20], 20 and
80 nm (10 mg/kg bw) [21], 30 (10 mg/kg bw), and 70 nm
(40 mg/kg bw) [19], 70 nm (10, 30 mg/kg bw) [15,16], 110
nm (25, 50 mg/kg bw) [17], or 100 and 200 nm (50 mg/kg
bw) [18]. This difference, between our observations and
literature, is most likely caused by the use of different ad-
ministration routes, potentially leading to much higheror NM-202 for 28 or 84 days. (A, B) Light microscopic images of an
agnification: 200x), and (B) NM-202 high dose (magnification: 200x).
ification: 200x), and (D) apoptosis after 28-days of exposure (NM-202
(E) Necrosis after 28-days of exposure (NM-202 medium dose;
SAS high dose (magnification 100x), and (G) NM-202 high dose
Figure 6 Histopathological evaluation of livers from animals
treated with SAS or NM-202 for 28 or 84 days. (A) The number
of mononuclear inflammatory cells (given per cm2) in liver tissue
after 28-, or 84-days of exposure (mean ± standard error of the mean;
n = 5). (B) The number of apoptotic cells (given per cm2) in liver
tissue after 28-, or 84-days of exposure (mean ± standard error of the
mean; n = 5). (C) The number of slides (out of a maximum of 10
evaluated slides) in which fibrosis occurred. * Significant difference
versus the control at that day.
Figure 7 Histological and electron microscopical images from
the liver. (A) Light microscopic image of a macrophage (indicated
by the circle) in liver tissue from an animal treated with the highest
dose of SAS for 84 days, and (B) a corresponding SEM-EDX graph of
the same macrophage (indicated by the rectangle) in which (C) the
elemental composition was analyzed.
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particles that were synthesized by a precipitation process,
possessing different physicochemical properties.
After 84-days of exposure, the occurrence of periportal
fibrosis in the liver (Figure 5F and G) was significantly
increased in the NM-202 treated animals (p = 0.021), as
compared with the control animals (Figure 6C; Additional
file 1: Table S9). In the SAS treated animals the presence
of fibrosis appeared to be increased too, but this was
not significant (p = 0.073). In literature, liver fibrosis
was reported in animals receiving monodisperse silica
nanoparticles, synthesized by precipitation, with a sizeof 70 nm intravenously, at the lowest repeated dose of
10 mg/kg bw every 3 days for 4 weeks [16]. Furthermore,
previous studies have suggested specific uptake of silica
particles, produced by precipitation, in liver macrophages
[16,36,41]. However, we could not confirm this by using
SEM-EDX analysis on liver slides (Figure 7).
Whole genome gene expression analysis was per-
formed on mRNA isolated from liver homogenates of
samples from animals exposed to SAS and NM-202 for
28-, or 84-days. In concordance with the histopatho-
logical data, gene set enrichment analysis did not reveal
a significant upregulation of gene expression in gene sets
correlated to inflammatory processes (data not shown).
Also expression analysis of individually selected genes
coding for cytokines involved in inflammatory processes
that were previously shown to be affected by exposure
to silica nanoparticles [16,17,20,21,42] did not show
significantly altered gene expression levels (Additional
file 1: Table S10). Further analysis revealed a significantly
induced gene expression in a fibrosis-related gene set for
samples of NM-202 treated animals after 84-days of ex-
posure, but not for SAS treated animals (Figure 8). Com-
parison of gene expression in the individual control rats
versus the average gene expression of all control rats, in-
dicated that there was low variation in gene expression
within the control group. It should be noted that, al-
though the observed induction of gene expression in
Figure 8 Transcriptomic analysis of livers from animals treated with SAS or NM-202 for 84 days. Heatmaps represent gene expression
profiles of gene sets related to fibrosis in liver tissue samples after 84-days of exposure. The red and green colours indicate up- or down-
regulation of gene expression (2 log expression ratio) for each individual rat in the treatment groups (n = 5) and in the control group (n = 4)
versus the average expression of that gene in the control group. Only genes that were up- or downregulated > |1.2x| versus the average control in
≥3 out of the 5 rats were selected. The results indicate up-regulated fibrosis related gene expression in the NM-202 treated animals after 84 days
of exposure. Comparison of gene expression in the individual control rats versus the average gene expression of all control rats, indicated that
there was a low variation in gene expression within the control group.
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animals, the observed differences in gene expression at
a single gene level were low (i.e. as demonstrated in
Figure 8, a threshold was set at > |1.2x| with a maximum
increased expression of 5.4x versus the average control)
and no effects were observed in any of the treatment
groups after 28-days of exposure. Nevertheless, gene set
enrichment analysis also showed significant enrichment
of gene sets related to activated hepatic stellate cells,
NF-κB target signaling, and D-galactosamine (i.e. a sin-
gle i.p. exposure dose of 3000 mg/kg for 24h) or LPS
(i.e. a single i.p. exposure dose of 3 mg/kg for 24h) treat-
ment in the NM-202 treated animals after 84-days of
exposure (Figure 8). These gene sets can be directly con-
nected to liver fibrosis. Activated hepatic stellate cells
are involved in the production of extracellular matrix
proteins like collagen, leading to the formation of fi-
brotic tissue, while NF-κB plays several important roles
in the development of liver fibrosis [43]. Treatment with
D-galactosamine and LPS has been described to induce
liver fibrosis in rodents [43]. Yet, biochemical blood pa-
rameters related to liver intoxication were not affected.
This might be indicative of only generally mild effects.
Alternatively, it has been shown in animal models, in
which chronic fibrosis of the liver was induced by intra-
peritoneal injection of dimethylnitrosamine, that chronic
liver fibrosis can be accompanied by base levels of AST
in blood [44].In summary, quantitative histopathological analysis
showed no significant biological effects in the SAS treated
animals. In the NM-202 treated animals, an induction of
fibrosis in the liver was observed after 84 days of treat-
ment, while no silica accumulation was detected in the
liver. This observation was in line with the outcome of
transcriptome analysis, showing an induced gene expres-
sion in fibrosis-related gene sets in the NM-202 treated
animals after 84 days. At the single gene expression level
this induction in gene expression remained relatively low.
Taken together, these results point toward the induction
of biological effects in the liver by NM-202 treatment, but
the biological relevance of the observed responses requires
further study.
While the SAS and NM-202 powdered materials used
in this study are both produced pyrogenically, both ma-
terials differ in some aspects. SAS and NM-202 have a
different specific surface area (i.e. 380 and 200 m2/g for
SAS and NM-202 respectively). The silica fraction in the
nano-size range in the feed mixtures used in this study
was larger in the case of feed mixtures containing NM-
202 than SAS, as determined by HDC-ICP-MS, and the
carbon content on the surface of the materials might
have been slightly different between the two materials,
as determined by XPS, EDX and FTIR. After 28 days of
exposure, none of the rats showed clearly elevated levels
of total silica content in tissues, except for the lower
dosed NM-202 animals that showed significant increases
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versus the controls. Accumulation of silica in tissues
after 84 days of exposure was demonstrated for the SAS
exposed animals, but not for the NM-202 exposed ani-
mals. The presence of nano-sized silica in liver could not
be detected with SEM-EDX analysis in any of the treated
rats. Finally, no systemic toxicity or immunotoxicity was
observed.
Conclusions
We conclude that, oral exposure of rats to NM-202 re-
sulted in biological effects on the liver after 84 days of
exposure, whereas exposure to SAS did not, which
might have been caused by minor variations in the start-
ing material (i.e. surface area, carbon content on the sur-
face, and the amount of silica in the nano-size range in
the feed matrix). However, at present it is not clear how
these different material properties (see Table 2) relate to
the observed effects. While not statistically significant,
the total silica content in tissues appeared to be lower in
the higher-dosed animals compared with the lower-
dosed animals, in particular for NM-202. Due to tech-
nical limitations of detection equipment we could not
determine the amount of silica in the nano-size range in
tissues from the exposed animals, nor elucidate in which
form silica was taken up. Clearly, the liver effects that
were observed in the present oral exposure study are
much lower in severity and incidence than in previous
studies reported by others, in which silica nanoparticles
(produced by precipitation) had been systemically ad-
ministered. The observed liver effects appeared to be
mild and were not accompanied by changes in biochem-
ical markers in blood, but supported by mild changes in
transcriptome analysis data from the liver. Additional
studies seem warranted to further evaluate the biological
relevance of the observed fibrosis in liver of NM-202 ex-
posed animals and possible accumulation of silica in the
spleen of SAS exposed animals. Using in vitro digestion
studies, we showed that the intestinal content of the mid
and high dosed groups had stronger gel-like properties
than the intestinal content of the lowest dose groups.
This implies also low gelation of silica in the human in-
testine, and high bioaccessibility of the silica at realistic
consumer exposure levels. Therefore, future studies
should include lower dosages more representative of
current human exposure, since only the high doses of
SAS and NM-202 were used for the 84-day exposure in
the present study.
Methods
Study materials and preparation of animal feed
A commercially available food additive, hydrophilic
pyrogenic synthetic amorphous silica (SAS) with a pri-
mary particle size of 7 nm, a specific surface area of 380m2/g, and a purity of 99.8% was used, kindly donated
by Evonik Degussa GmbH (Frankfurt, Germany). In
addition, Joint Research Centre (JRC, Ispra, Italy) Nano-
materials Repository; hydrophilic pyrogenic silica (NM-
202) was used, which was kindly donated by the JRC of
the European Commission. NM-202 has a specific sur-
face area of 200 m2/g, a purity of 99.9%, and a primary
particle size between 10 and 25 nm.
SAS or NM-202 was mixed with standard feed and
chocolate milk was added to increase palatability, which
was assessed in a pilot experiment. SAS or NM-202 was
mixed by hand-stirring to a thick paste with chocolate
milk (Chocomel, Nutricia, The Netherlands) and ground
standard diet pellets (RMH-B, ABDiets, The
Netherlands) in a ratio of 1:8:1 respectively, by weight.
Total intended silica content of the mixtures (both SAS
and NM-202) was 99 mg/g and was fed in different
amounts to rats to achieve the desired daily dosage
(Table 1; Additional file 1: Table S1). Higher dosed ani-
mals were offered more of the feed mixture than lower
dosed animals. All animals of each group daily con-
sumed the complete amount of food mixture that was
offered within the two hour exposure time frame. For
control groups, feed without SAS or NM-202 was pre-
pared, containing only chocolate milk and ground stand-
ard diet pellets. To adequately compensate for the
amount of chocolate milk, an average amount of choc-
olate milk as offered to the treated animals was chosen.
This resulted in a ratio of 3:2 of chocolate milk and
ground pellets respectively, by weight. Thus, animals in
the different treatment groups received the following
amounts of chocolate milk through feeding of the feed
mixtures;. 0.8, 8.1 and 20 g/kg/ bw/day for the SAS low,
medium, and high dose groups respectively, 0.8, 4.1 and
8.1 g/kg bw/day for the NM-202 low, medium, and high
dose groups respectively, and 6.1 g/kg bw/day for the
control animals. The feed mixtures were prepared
freshly three times a week.
In vivo experimental design
Six-week-old male specific pathogen free Sprague–Dawley
rats were purchased from Harlan (Horst, The Netherlands).
Animals were individually housed in polycarbonate cages
with cage enrichment and were allowed to acclimatize
for three weeks before the start of the experiment.
Room temperature was ~20°C with a relative humidity
of ~55%. Individual housing was necessary, because
rats were individually offered prepared food with SAS,
NM-202 or vehicle. A reversed 12-h light/dark cycle
was used to feed the rats in their active period and feed and
water was given ad libitum, except for a two hour fasting
period before the prepared feed was offered to the animals,
and the following exposure period. Rats were allowed
to consume all prepared feed, immediately thereafter
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again. During the entire study, rats ate all silica containing
food mixtures or vehicle mixtures during the exposure
period of two hours. The study was performed according to
the national guidelines for the care and use of laboratory
animals after approval of the animal welfare committee of
Wageningen University.
At the start of the experiment the average body weight
of the 9 weeks old animals was ~280 g and rats were
randomly divided into 10 groups (n = 5). Seven groups
of rats were fed SAS or NM-202 in different dosages or
vehicle for 28 days, in addition the highest dosed groups
of SAS and NM-202 and a control group were fed for 84
days. The groups for 28-day exposure were: 1) SAS; 100
mg/kg bw/day, 2) SAS; 1000 mg/kg bw/day, 3) SAS;
2500 mg/kg bw/day, 4) NM-202; 100 mg/kg bw/day; 5)
NM-202; 500 mg/kg bw/day; 6) NM-202; 1000 mg/kg
bw/day and 7) control. For the 84-day exposure, the
groups were divided into: 8) SAS; 2500 mg/kg bw/day,
9) NM-202; 1000 mg/kg/day and 10) control. Dosages
were chosen around the previously observed LOAEL of
1500 mg/kg bw/day for SAS [4]. The medium and high
doses of NM-202 were chosen to be lower than those of
SAS, because the material characterization showed a
higher fraction of silica in the nano-size range in the
feed matrix for NM-202. All rats were weighed daily.
One day after the last exposure of the 28-day exposure
groups (i.e. the first 7 groups), the animals were eutha-
nized by CO2/O2 inhalation and the following organs
were excised aseptically, weighed and placed on ice: liver,
kidneys, spleen, brain, testis and the MLNs. Parts of the
liver and the epithelium of the jejunum were also stored
in liquid nitrogen, and parts of the jejunum, liver, kidney
and spleen were fixed in 10% formalin. Furthermore,
blood was collected on heparin and stored on ice, as well
as the stomach, small (duodenum, jejunum, ileum) and
large intestinal contents. One day after the last exposure
of the 84-day exposure groups (i.e. group 8–10), all ani-
mals were euthanized and organs collected according to
the same protocol as applied for the 28-day exposure
groups.
Total silicon content was determined with inductively
coupled plasma mass spectroscopy (ICP-MS) in liver,
kidney, spleen, brain and testis. Furthermore, hydro-
dynamic chromatography (HDC) ICP-MS was applied to
detect silica particles in the nano-size range (i.e. with a
size of 5 – 200 nm) in gastrointestinal contents. Sys-
temic toxicity was monitored by analysis of biochemical
markers in serum and by histopathological analysis of
jejunum, liver, kidney, and spleen. Immunotoxicity was
evaluated by measuring antibody levels in blood, analysis
of the proliferation of T- and B-cells isolated from the
spleen end mesenteric lymph nodes (MLN) in response
to lipopolysaccharide (LPS) or concanavalin A (Con A),by evaluating cytokine levels in culture media from these
proliferating T- and B-cells, and by measuring the activ-
ity of natural killer (NK)-cells isolated from the spleen.
Material characterization
Both SAS and NM-202 were characterized in aqueous
suspensions by SEM. SAS and NM-202 were suspended
in LC/MS grade water (Biosolve, Valkenswaard, The
Netherlands), containing 0.05% BSA as a stabilizing agent,
to a concentration of 10 mg/ml. Suspensions were vor-
texed for 1 min at full speed, followed by sonication at
20°C at 100% output (4 W specific ultrasound energy (240
J/m3), using a Branson 5510 water bath sonicator (Emer-
son, USA) for 30 min. Next, the suspensions were further
diluted to a final concentration of 10 μg/ml in LC/MS
grade water (Biosolve) and sonicated again at 20°C at
100% output in a water bath sonicator (Emerson) for 30
min. Furthermore, SAS and NM-202 were characterized
in the feed matrix prepared as described earlier and di-
luted 100 times. For SEM measurements, droplets of
the suspensions were put on a nickel coated Nuclepore
track-etched polycarbonate membranes and analyzed
with high-resolution field emission gun scanning electron
microscopy (FEG-SEM) on a Tescan MIRA LMH FEG-
SEM operated at 15 kV in combination with a Bruker EDX
spectrometer with a XFlash 4010 detector with an active
area of 10 mm2 and super light element window (SLEW),
which allows X-ray detection of elements higher than
borium (Z > 5). The spectral resolution of the detector is
123 eV (Mn (10kcps) ave FWHM). The SEM was equipped
with a Scandium SIS software package (Olympus Soft
Imaging Solutions GmbH, Germany) for automated particle
analysis. With this system the filter area is automatically
inspected on a field-by-field basis. In each field of view
particles are recognized using a pre-selected grayscale
video threshold (detection threshold level) to discriminate
between a particle and the filter background. The analyses
were conducted using the secondary electron (SE) mode.
The particle size distribution is based on the projected
area equivalent diameter (dpa). Magnifications of 25.000X
(image area: 6 × 8 μm) and 75.000X (image area: 2 × 2.7
μm) were chosen in order to cover the full size range from
25–400 nm. Per size bin (25–40, 40–65, 65–100, 100–160,
160–250, 250–400 nm) a minimum of 50 particles was
measured; in total more than 1000 particles were mea-
sured. EDX analysis of the material surface included a
correction for the background signal. This was per-
formed by subtraction of the background signal, using
nickel as a reference element (which is present as a thin
layer on the filter).
IR spectra of both materials were acquired on a Bruker
Tensor 27 FTIR spectrometer equipped with a single
reflection Platinum ATR accessory, at a resolution of
2 cm-1.
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ously [23]. SAS characterization was performed at the
same institute, using the same protocol and equipment.
The measurements (consisting of four technical repli-
cates) were performed using an AXIS ULTRA Spectrom-
eter (KRATOS Analytical, UK) and Vision2 software
(Kratos Analytical, UK) was used for data processing.
The XPS analysis provides information on the surface
composition of the analyzed material (down to a depth
of 10 nm) with a detection limit of ~0.1% of the atoms
and an estimated 10% accuracy in the measurement of
elemental compositions. More detailed information re-
garding the measurement is given in Additional file 1.
In vitro digestion of feed samples
The used in vitro digestion model has previously been
described [9,24-26]. Briefly, the model consists of three
phases; the saliva, gastric, and intestinal phase. The dis-
solution and gelating behavior of SAS and NM-202 in
the intestinal environment was studied after the mate-
rials passed all three phases. All artificial juices for the
digestion experiments were prepared on the day before
the actual digestions. The pH values of the juices were
checked and, if necessary, adjusted to the appropriate
interval with NaOH (1M) or HCl (37% w/w). The con-
stituents and concentrations of the various synthetic
juices are as shown in Additional file 1: Table S11. Be-
fore the start of the digestions, all digestive juices were
heated to 37 ± 2°C and incubations are carried out in a
head-over-head rotator at 37 ± 2°C. Experiments for the
rheological measurements were performed in duplo, and
six replicate samples were used for the dissolution be-
havior experiments.
For the rheological measurements the digestion started
by introducing 2 mL of artificial saliva to the SAS/NM-
202/control feed mixture. The feed mixture consisted
of 8 g of chocolate milk, 1.0 g of powdered standard
diet, and 0–1.0 g of SiO2, dependent on the desired final
concentration in the intestinal phase (i.e. 0, 10, 50, 75
mg/mL). This mixture was rotated head-over-head for 5
min at 55 rpm at 37 ± 2°C. Subsequently, 4 mL of gastric
juice was added, the pH adjusted to pH 2.0 ± 0.5, and
the mixture was rotated head-over-head for 2 h at 37 ±
2°C. Finally, 4 mL of duodenal juice, 6 mL of bile juice,
and 0.7 mL of NaHCO3 solution were added. The pH
was adjusted to pH 6.5 ± 0.5, and the mixture was again
rotated head-over-head for 2 h at 37 ± 2°C. Subse-
quently, the samples were used for rheological measure-
ments. Additionally, a subsample of the suspensions was
taken for SEM-EDX analysis to characterize the material
after in vitro digestion.
For the dissolution measurements, SAS and NM-202
suspensions of 1 mg SiO2/mL were prepared in Milli-Q
with 0.05% BSA. Subsequently, 630–2115 μL of thesedilutions, depending on the desired final concentration
in the intestinal phase (i.e. 50, 75, 150 μg/mL) were
added to the first phase of the digestion model (i.e. 2 mL
of artificial saliva). The digestion procedure was per-
formed as described above. At the end of the digestion
experiment, 4 mL of all samples were ultrafiltered by
centrifugation through a cellulose filter with a nominal
cutoff value of 3 kDa (Ultra-4, Amicon). The total silica
content in the unfiltered and filtered suspensions were
measured by ICP-MS.
Rheological measurements
The visco-elastic behavior of the SAS, NM-202, and
control feed mixtures following in vitro digestion was
analyzed by rheological measurements. Oscillatory mea-
surements were performed using a Physica MCR 301
(Anton Paar, Austria) stress controlled rheometer with a
concentric double gap cylinder geometry (DG 26.7) to
determine the storage modulus (G’) and loss modulus
(G”) of the samples. The samples were subjected to a
strain sweep with strains ranging from 1-500%, at a fre-
quency of 1 Hz.
Determination of silica (in the nano-size range) by (HDC)
ICP-MS
The size and concentration of silica in the nano-size
range (i.e. between 5–200 nm) was determined by HDC-
ICP-MS in the feed mixtures and in the stomach, small
and large intestinal contents of the rats after 28 days of
exposure. Samples were homogenized by mixing and a
subsample was collected for analysis. The subsample
was sonicated in LC/MS grade water to prepare an
aqueous suspension, which was filtered through a 5 μm
filter (Acrodisc, Pall Lifer Sciences, USA) before HDC-
ICP-MS analysis.
The HDC system was a Thermo Scientific Spectra sys-
tem P-4000 liquid chromatograph (Waltham, MA, USA)
equipped with a PL-PSDA HDC cartridge, type 1, length
800 mm, diameter 7.5 mm, packed with non-coated, non-
porous silica spheres (Agilent Technologies, Wokingham,
UK). The eluent was an aqueous 10 mM solution of
sodium n-dodecyl sulphate (SDS) with a flow rate of
1.0 ml/min. Sample injection volumes were 50 μL. The
ICP-MS was a Thermo X Series 2 (Waltham, MA, USA),
equipped with an autosampler, a Babington nebulizer and
operated at an RF power of 1400 W. Data acquisition was
performed in the selected ion monitoring mode monitor-
ing m/z ratios of 28 and 29 that are characteristic for
silicon. Polyatomic interference at these ion masses is un-
avoidable and resulted in a high, but relatively stable,
background signal due to N2. Acquiring data in the he-
lium collision mode did not improve the signal/noise ratio
and was not applied since it resulted in an overall lower
sensitivity. The Si signal of peaks in the chromatograms
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baseline in the same chromatogram. Aqueous suspensions
of silica nanoparticles with sizes ranging from 32 to 500
nm (Microsil microspheres, Bangs Laboratories, USA)
were used to calibrate the size separation of the HDC col-
umn, while a standard of 32 nm silica nanoparticles was
used for quantitation and checking system performance.
Data are presented as a weight percentage of silica in the
nano-size range relative to the total amount of silica in the
same samples.
The total silicon content was determined in the stand-
ard rat feed pellets, the prepared feed, with or without
SAS or NM-202, in the drinking water, in the stomach
and gut content and in the tissues. For this, 1–2 grams
of sample was added to a perfluoroalkoxy digestion vial,
followed by the addition of 6 ml 70% nitric acid and 1
ml of 40% hydrogen fluoride. The samples were digested
in a microwave system for 45 min at ~250°C, 70 bar.
Following digestion and cooling to room temperature,
MilliQ water was added to a total volume of 150 ml.
This solution was shortly shaken by hand and two times
further diluted to a total volume of 300 ml. Finally, the
extracts were analyzed by ICP-MS using the same sys-
tem and settings as described above. The use of glass
equipment during sample preparation and (HDC) ICP-
MS analysis was avoided to prevent Si contamination.
Also internal control samples were evaluated to assure
the absence of Si contamination. Si measurement data
were converted to SiO2 and presented as SiO2 through-
out the text. The limit of detection in tissues, the stom-
ach, small and large intestinal contents was set at 35 mg
Si/kg (75 mg SiO2/kg), with a measurement error of ± 15
mg Si/kg for concentrations between 35 and 100 mg Si/
kg and 20% at concentrations >100 mg/kg. In water and
intestinal juices (for the in vitro digestion experiments)
the limit of detection was set at 5 μg/ml based measure-
ments in blanks.
The performance of the HDC-ICP-MS analysis in
terms of response and retention time stability was deter-
mined as described earlier [9] as the standard deviation
in the average response and retention time of the quanti-
tation standard in each analysis series. The reproducibil-
ity standard deviation of the response of the quantitation
standard was 20%, and that of the retention time win-
dow <2%. Compared to usual contaminant analysis the
reproducibility standard deviation of the response is
relatively high for two reasons. First, the ICP-MS signal
for Si suffers from a high background due to the pres-
ence of N2 and CO, which has to be subtracted to isolate
the true Si signal of the analytes. Secondly, since a “size
range” has to be determined no clear narrow peaks as
in regular gas or liquid chromatography are observed,
but broader peaks depending on the size distribution of
the particles.The recovery of nano-sized silica (by HDC-ICP-MS) is
determined by spiking blank samples with nano-sized
silica and analyzing these control samples with the ac-
tual samples. The average recovery of the added nano-
sized silica (32 nm colloidal silica material, stabilized at
pH 8.6, was obtained from the Institute for Reference
Materials and Measurements (IRMM), European Com-
mission Joint Research Centre, Geel, Belgium) was 83 ±
21%. The SANCO/10684/2009 document concerning
method validation and quality control procedures for
pesticide residue analysis in food and feed states that the
recovery should be between 70 and 120% and that the
within lab reproducibility of a method should not exceed
20% [45]. This means that the recovery is acceptable
while the reproducibility is on the limit. This however,
was considered acceptable since the SANCO document
is applicable to well-established methods for well-
defined analytes such as pesticides and not to less well-
defined particulate materials as in this study.
Blood biochemistry determination
In plasma, taken after 28-days of exposure, alanine ami-
notransferase (ALT), aspartate aminotransferase (AST)
and alkaline phosphatase (ALP) activity, creatinin, total
protein and urea, were determined using standard kits
(Beckman-Coulter, Woerden, the Netherlands). In plasma,
taken after 84-days of exposure, the same biochemical
markers as for the 28-day exposure were determined, as
well as lactate dehydrogenase (LDH) activity, uric acid,
Zn, Fe, HDL-, LDL- and total cholesterol, triglycerides,
and glucose levels using standard kits (Beckman-Coulter).
ALT, ASP, ALP, creatinin, total protein, urea, LDH, uric
acid, Zn, Fe, HDL, LDL and total cholesterol, triglycerides
and glucose were determined with a clinical autoanalyzer
(LX20-Pro, Beckman-Coulter) using standard kits which
have been developed for this system.
Immunotoxicity on mesenteric lymph nodes and spleen
The excised mesenteric lymph nodes (MLN) and ap-
proximately one third of the spleen of each rat were
stored separately in Iscove’s modified Dulbecco’s
medium (IMDM; Gibco, Grand Island, NY) on ice. The
organs were pressed gently through a cell strainer (70-μm
nylon; Falcon, Becton-Dickinson Labware, Franklin Lakes,
NJ) and the cells were suspended in 25 ml IMDM, supple-
mented with 10% fetal calf serum (FCS; PAA, Linz,
Austria), 100 IU/ml penicillin, and 100 μg/ml strepto-
mycin, referred to as complete Iscove’s medium. Next, the
cell suspensions were centrifuged at 300g for 10 min (4°C)
and the pellets were resuspended in 20 ml complete
Iscove’s medium. Finally, cells were counted using a
Coulter Counter (Coulter Electronics, Luton, UK). For the
lymphocyte transformation test, 4*105 cells, isolated from
the MLN or spleen, were cultured in six-fold in 150 μl
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plates (Greiner, Frickenhausen, Germany). In three of the
six wells of the first Plate 15 μg/ml LPS (final concentra-
tion) was present (B-cell proliferation). In parallel, in three
of the six wells of the second Plate 5 μg/ml Con A (final
concentration) was present (T-cell proliferation). After 24
h (LPS) or 48 h (Con A) incubation in a humidified at-
mosphere containing 5% CO2 at 37°C, 37 kBq [methyl-
3H]thymidine ([3H]TdR; Amersham, Little Chalfont, UK)
was added to the wells. Cells were incubated for another
24 h followed by harvesting of the cells onto glass-fibre fil-
ters (LKB-Wallac, Espoo, Finland) using a multiple cell
culture harvester (LKB-Wallac). Radioactivity was counted
using an LKB Wallac 1205 Betaplate Beta Liquid Scintilla-
tion Counter.
In addition, natural killer (NK) cell activity was evalu-
ated in cells from spleen cell suspensions by overnight
incubation at 37°C as described elsewhere [46]. The ac-
tivity of NK cells was measured as the ability of 2*106
spleen cells to lyse 1*104 51Cr-labelled YAC-1 target cells
during a 4 h co-incubation in 96-well cell culture plates
(Greiner) at 37°C. Radioactivity was counted using a
Perkin-Elmer Packard Cobra II Auto Gamma Counter.
NK-cell activity was given as a percentage of the max-
imal release by YAC cells, calculated as (radioactivity
counts in the supernatant minus spontaneous release by
YAC)/(maximal release by YAC cells minus the spontan-
eous release by YAC cells).
Plasma IgG and IgM levels
Plasma IgG and IgM levels were measured using rat IgG
and rat IgM ELISA kits (E25G and E25M, respecively;
ICL, Gentaur, the Netherlands). IgG was measured at
20,000-, 40,000-, and 80,000-fold serum dilutions, while
IgM was measured at a 600-fold serum dilution.
Cytokine levels in culture supernatants
MLN and spleen cells were incubated with LPS and Con
A using the same cell concentrations and LPS and Con
A concentrations as described above. Incubation with
LPS was for 48 h, while incubation with Con A was for
72 h. To determine the cytokine levels in the culture su-
pernatants a 4-plex panel (Bio-Rad, Hercules, CA) was
used in case of LPS-stimulation (IL-1β, IL-6, IL-10, and
TNF-α), while a 9-plex panel (Bio-Rad) was used in case
of Con A-stimulation (IFN-γ, IL-1β, IL-2, IL-4, IL-6, IL-
10, IL-13, IL-17α, and TNF-α). A volume of 100 μl Bio-
Plex assay buffer (Bio-Rad) was added to 96-wells filter
bottom plates (Bio-Rad) to pre-wet the plate. Buffer was
removed by vacuum after each incubation or wash step.
Beads were diluted in assay buffer, and 50 μl/well was
added. Then, the plates were washed 2 times with 100 μl
Bio-Plex wash buffer (Bio-Rad). Dilution series of the
cytokine standards were made ranging from 32,000 to0.18 pg/ml. Fifty μl of the standards and cell culture su-
pernatants was added to the wells and the plates were
vortexed at 1100 rpm for 30 s and incubated at RT for
30 min while vortexing at 300 rpm. After incubation the
plates were washed 3 times with 100 μl wash buffer. De-
tection antibody was diluted in detection antibody dilu-
ent (Bio-Rad), and 25 μl/well was added. The plates
were again vortexed at 1100 rpm for 30 s, incubated at
RT for 30 min while vortexing at 300 rpm and washed 3
times with 100 μl assay buffer. Next, streptavidin-PE was
diluted in assay buffer and 50 μl/well was added. The
plates were incubated for 10 min at RT. After 3 times
washing with 100 μl wash buffer the beads were resus-
pended in 125 μl assay buffer and read on a Bio-Plex
(Bio-Rad). Results were obtained at low photomultiplier
tube settings.
Histological analysis
For histopathology, liver, jejunum, kidney and spleen
samples were harvested and fixed in 10% neutral buff-
ered formalin. Subsequently, they were dehydrated in a
series of ethanol and embedded in paraffin. Approxi-
mately 4 μm thick sections were cut, mounted on glass
slides and stained with hematoxylin and eosin (H&E).
The sections were observed under an optical microscope
(Olympus, BX 60, Japan) at different magnifications. All
quantitative histological analyses were performed blind
to the treatment of the groups.
For livers, 10 images (each of 1 mm2) in 10 slides (3
μm apart) in one of the liver lobes per animal were eval-
uated. Per slide the total number of inflammatory foci,
and the total number of inflammatory cells in these foci
was scored. Only foci consisting of more than 10 inflam-
matory cells were included in the analysis. Furthermore,
the total number of apoptotic cells was scored per slide,
as well as the presence of necrosis or fibrosis. Necrosis
resulted in a positive or negative score, leading to a
minimum score of 0 positive slides and a maximum
score of 10 positive slides per rat, whereas fibrosis was
also indexed on severity per slide (0,=not remarkable, 1
= very mild, 2 = mild, 3 =moderate, 4 = severe, 5 = very
severe). Apoptotic cells were also visualized using an
Apoptaq® Peroxidase in situ apoptosis detection kit
(Millipore Corporation, Billerica, USA). Representative
micrographs were recorded using a Leica DFC 450 cam-
era (Leica, The Netherlands) fitted onto the microscope.
In jejunum samples, 5 μm transverse sections were
cut. The villus height, crypt depth, and villus:crypt ratio
were measured using an image-analyzing software pack-
age (Cell^D; Olympus Soft Imaging Solutions GmbH,
Germany), coupled to an optical microscope (Olympus,
Japan). A minimum of 10 villi was measured in one slide
per animal. All villus height having lamina propria were
measured from the villus tip to the end of the base,
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from the valley between individual villi to the basolateral
membrane.
For SEM-EDX analysis of liver tissue, tissues were
fixed and dehydrated as described above, but sections
were mounted on silicium free ThermanoxTM coverslips
(Nunc, Germany). Sections were H&E stained and ob-
served under an optical microscope as described above
and then deparaffinized in xylene overnight. The sec-
tions were subsequently sputter coated with chromium
using a K575X turbo sputter coater (Emitech) and ana-
lyzed with SEM-EDX as described before. EDX-mapping
analysis was used to search for clusters with increased
silica content in the tissue. Here, a detection limit of 100
mg silica/kg tissue was estimated. Liver macrophages,
selected with light microscopy, were analyzed individu-
ally for the presence of silica in the cells with SEM-EDX.
Statistical analysis
Results were statistically analyzed using Prism (v5;
GraphPad Software, Inc., La Jolla, USA) and GenStat
15th edition (version 15.2.0.8821) software. Body- and
organ weights, ICP-MS, cytokine release, gene expres-
sion of individual genes, and biochemical analysis results
were analyzed with a two-way ANOVA with a Bonfer-
roni post-test. HDC ICP-MS, lymphocyte transform-
ation, NK-activity, and antibody release results were
analyzed with a one-way ANOVA with a Bonferroni
post-test. Outliers in the (HDC) ICP-MS results were re-
moved according to Chauvenet’s criterion. All histopath-
ology data was analyzed with a logarithmic regression
analysis using a Poisson distribution, except for the ne-
crosis and fibrosis data, which were analyzed by logistic
regression using a binomial distribution between 0 and
10. For all statistical results, a p-value of ≤ 0.05 was con-
sidered significant.
Transcriptomic analysis
To study the effects of the treatment on the transcrip-
tome of liver cells, a piece of liver tissue was immedi-
ately frozen in liquid nitrogen during dissection after
the 28-, or 84-day exposure and stored until further
use. 1250 μl Trizol and 10–15 zirconia/silica beads (Lab
Services BV, Breda, The Netherlands) were added to
the tissue after which the tissue was homogenized
(homogenizer: Precellys 24, Amsterdam, The Netherlands)
at 6500 bpm for 2x 15 s with a 30 s interval. The mixture
was centrifuged at 12,000 g for 15 min at 4°C. The super-
natant was mixed with 300 μl chloroform, incubated at
room temperature for 3 min and centrifuged at 12,000 g
for 15 min at 4°C. The aqueous phase was transferred to
be mixed with 750 μl isopropyl alcohol, which precipitates
total RNA. After overnight incubation at −20°C and cen-
trifuging (20 min, 12,000g at 4°C), the pellet was washedwith 75% ethanol, centrifuged again at 12,000g for 10 min
at 4°C, and resuspended in RNase-free water. Subse-
quently, RNA was further purified using the RNeasy Mini
Kit (Qiagen, Venlo, The Netherlands). Purity, and concen-
tration of the RNA were assessed using the nanodrop
(Isogen, De Meern, The Netherlands) at wavelengths of
230, 260, and 280 nm and RNA integrity was checked
on an Agilent 2100 Bioanalyzer (Agilent Technologies,
Amsterdam, The Netherlands) with 6000 Nano Chips.
RNA was judged as suitable only if samples showed intact
bands of 18S and 28S ribosomal RNA subunits, displayed
no chromosomal peaks or RNA degradation products,
and had a RNA integrity number (RIN) above 8.0.
For each individual rat, total RNA (100 ng) of the liver
was labeled using the Ambion WT expression kit (Life
Technologies, Bleiswijk, The Netherlands). RNA samples
were hybridized on Affymetrix GeneChip Rat Gene 1.1
ST arrays. Hybridization, washing, staining and scanning
was performed on an Affymetrix GeneTitan instrument.
Array data were analyzed using an in-house, on-line sys-
tem [47]. Shortly, probesets were redefined according to
Dai et al. [48] using remapped CDF version 15.1 based
on the Entrez Gene database and a robust multi-array
(RMA) analysis was used to obtain expression values
[49,50]. Gene expression data from one rat in the con-
trol and NM-202 medium group did not pass the quality
control criteria and were excluded.
Spot intensities were floored to 17, which was followed
by 2 log mean- centering and calculation of 2 log ratios
of treatments versus the average of the control samples.
Hierarchical clustering was done using the programs
Cluster 3.0 (uncentered correlation; average linkage clus-
tering) and Treeview 1.6 (Eisen Lab, USA). Gene set en-
richment analysis (GSEA) was performed to discover the
differential expression of biologically relevant sets of
genes [51]. For this, several genes sets related to com-
mon liver processes were composed using the text-
mining tool Anni 2.0 (http://www.biosemantics.org/anni)
[52]. Furthermore, several gene sets related to specific
toxicological responses in the liver, composed from lit-
erature and/or in-house data were used, as well as pub-
licly available gene sets (Additional file 1: Table S12).
Significantly enriched gene sets were selected on the
basis of a p-value <0.01 in combination with an FDR-
value <0.25 according to GSEA statistics. Genes that
contributed to the enrichment of these sets were se-
lected and filtered on >1.2x up- or down-regulated ver-
sus the average of the controls in ≥ 3 out of the 5 rats.
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